| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |